# FDA recall D-0557-2022

> **Junp Hydration LLC** · Class I · drug recall initiated 2022-02-04.

## Product

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

## Reason for recall

Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

## Distribution

Product was distributed nationwide in the USA via Amazon Marketplace

## Key facts

- **Recall number:** D-0557-2022
- **Recalling firm:** Junp Hydration LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-02-04
- **Report date:** 2022-02-16
- **Termination date:** 2022-06-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Brooklyn, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0557-2022

## Citation

> AI Analytics. FDA recall D-0557-2022. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0557-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*